Package 59310-610-31

{"route": ["INTRAVENOUS"], "spl_id": "a6e253d0-2741-4a06-afa7-e3bd866b64ec", "openfda": {"nui": ["N0000191872", "N0000191871"], "unii": ["35A26E427H"], "rxcui": ["1746893", "1746898"], "spl_set_id": ["053b9158-2a5b-48b9-bf47-5fa78a35ec33"], "pharm_class_epc": ["Interleukin-5 Antagonist [EPC]"], "pharm_class_moa": ["Interleukin-5 Antagonists [MoA]"], "manufacturer_name": ["Teva Respiratory, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL, SINGLE-USE in 1 CARTON (59310-610-31)  / 10 mL in 1 VIAL, SINGLE-USE", "package_ndc": "59310-610-31", "marketing_start_date": "20160418"}, {"sample": true, "description": "1 VIAL, SINGLE-USE in 1 CARTON (59310-610-33)  / 10 mL in 1 VIAL, SINGLE-USE", "package_ndc": "59310-610-33", "marketing_start_date": "20170604"}], "brand_name": "CINQAIR", "product_id": "59310-610_a6e253d0-2741-4a06-afa7-e3bd866b64ec", "dosage_form": "INJECTION, SOLUTION, CONCENTRATE", "pharm_class": ["Interleukin-5 Antagonist [EPC]", "Interleukin-5 Antagonists [MoA]"], "product_ndc": "59310-610", "generic_name": "Reslizumab", "labeler_name": "Teva Respiratory, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "CINQAIR", "active_ingredients": [{"name": "RESLIZUMAB", "strength": "10 mg/mL"}], "application_number": "BLA761033", "marketing_category": "BLA", "marketing_start_date": "20160418", "listing_expiration_date": "20261231"}